Dupixent 00024-5915
Generic: Dupilumab
Product NDC
00024-5915- Manufacturer
- Sanofi-Aventis U.s. Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 19, 2020
- Listing Expires
- December 31, 2027
- Application
- BLA761055
Need to source Dupixent? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dupilumab | 300 mg/2mL |
Drug Class
Interleukin-4 Receptor alpha Antagonist [EPC]AntibodiesMonoclonal [CS]
Packaging Options(2)
2 SYRINGE, GLASS in 1 CARTON (0024-5915-02) / 2 mL in 1 SYRINGE, GLASS (0024-5915-00)
2 SYRINGE, GLASS in 1 CARTON (0024-5915-20) / 2 mL in 1 SYRINGE, GLASS (0024-5915-01)